PortfoliosLab logo
Natera, Inc. (NTRA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US6323071042

CUSIP

632307104

IPO Date

Jul 2, 2015

Highlights

Market Cap

$21.38B

EPS (TTM)

-$1.54

Total Revenue (TTM)

$1.83B

Gross Profit (TTM)

$1.13B

EBITDA (TTM)

-$170.27M

Year Range

$92.14 - $183.00

Target Price

$187.72

Short %

4.62%

Short Ratio

3.65

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Natera, Inc. (NTRA) returned -0.64% year-to-date (YTD) and 49.39% over the past 12 months.


NTRA

YTD

-0.64%

1M

6.25%

6M

17.41%

1Y

49.39%

5Y*

27.48%

10Y*

N/A

^GSPC (Benchmark)

YTD

-0.64%

1M

8.97%

6M

-2.62%

1Y

11.90%

5Y*

15.76%

10Y*

10.69%

*Annualized

Monthly Returns

The table below presents the monthly returns of NTRA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202511.76%-12.06%-9.11%6.73%4.21%-0.64%
20245.27%31.16%5.75%1.55%14.70%1.65%-5.45%15.50%7.35%-4.72%38.71%-5.65%152.71%
20236.87%13.09%14.36%-8.65%-7.12%3.29%-7.07%29.88%-24.66%-10.80%41.75%11.96%55.94%
2022-24.35%-6.94%-38.13%-13.67%4.47%-3.41%32.62%4.81%-11.04%7.17%-12.44%-2.31%-56.99%
20217.15%8.86%-12.53%8.35%-14.43%20.60%0.87%3.41%-5.90%2.81%-20.17%2.11%-6.16%
20203.92%8.27%-21.22%24.05%18.39%13.71%-3.69%32.67%13.39%-6.89%31.24%12.74%195.40%
2019-2.65%16.56%30.18%-7.32%19.83%20.44%-0.00%19.47%-0.46%17.44%-5.27%-7.67%141.33%
201815.80%-13.54%3.00%20.06%4.76%61.41%22.00%20.38%-13.39%-8.27%-21.13%-19.40%55.28%
2017-23.48%6.70%-7.22%2.03%13.15%6.05%-25.69%53.04%4.37%-14.74%-11.46%-7.61%-23.23%
2016-20.83%-21.05%41.04%3.15%40.43%-12.51%8.58%-24.05%11.66%-23.67%41.51%-2.42%8.43%
2015-20.45%-12.55%-31.42%-23.96%7.76%21.48%-52.51%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 88, NTRA is among the top 12% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of NTRA is 8888
Overall Rank
The Sharpe Ratio Rank of NTRA is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of NTRA is 8787
Sortino Ratio Rank
The Omega Ratio Rank of NTRA is 8383
Omega Ratio Rank
The Calmar Ratio Rank of NTRA is 9595
Calmar Ratio Rank
The Martin Ratio Rank of NTRA is 9191
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Natera, Inc. (NTRA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Natera, Inc. Sharpe ratios as of May 13, 2025 (values are recalculated daily):

  • 1-Year: 1.03
  • 5-Year: 0.46
  • All Time: 0.34

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Natera, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History


Natera, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Natera, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Natera, Inc. was 77.74%, occurring on May 11, 2022. Recovery took 588 trading sessions.

The current Natera, Inc. drawdown is 11.14%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-77.74%Sep 20, 2021163May 11, 2022588Sep 13, 2024751
-70.93%Jul 6, 2015151Feb 8, 2016613Jul 16, 2018764
-60.84%Aug 27, 201893Jan 9, 2019146Aug 8, 2019239
-57.25%Nov 20, 201981Mar 18, 202035May 7, 2020116
-30.81%Feb 16, 202168May 21, 202182Sep 17, 2021150

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Natera, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Natera, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 28.6% positive surprise.


-1.50-1.00-0.5020212022202320242025
-0.50
-0.70
Actual
Estimate

Valuation

The Valuation section provides an overview of how Natera, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for NTRA compared to other companies in the Diagnostics & Research industry. NTRA currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for NTRA relative to other companies in the Diagnostics & Research industry. Currently, NTRA has a P/S ratio of 11.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for NTRA in comparison with other companies in the Diagnostics & Research industry. Currently, NTRA has a P/B value of 17.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items